文献速递肝胆胰外科围术期管理与 ERAS

Tampa机器人难度评分系统的内部验证:实时评估新型机器人评分系统预测肝切除财务成本

Internal validation of the Tampa Robotic Difficulty Scoring System: real-time assessment of the novel robotic scoring system in predicting financial costs of hepatectomy.
PubMed 文献 · Surg Endosc · 2026-01-16

该研究对124例机器人肝切除患者回顾性应用Tampa机器人难度评分,按评分分为4组,分析评分与总住院费用、可变成本、固定成本及医院报销的关系。结果显示评分升高与总住院费用、可变成本、固定直接和间接成本显著增加相关,但医院报销未随手术复杂度线性增加,在最复杂病例中造成不成比例的财务负担。

要点

  • Tampa机器人难度评分与机器人肝切除的总住院费用、可变成本、固定直接和间接成本显著相关。
  • 医院报销未随手术复杂度线性增加,最复杂病例对医疗机构造成不成比例财务负担。
  • 该评分可用于术前手术规划、资源分配和财务风险评估,但需外部验证。

核心结论

  • Tampa机器人难度评分不仅能预测机器人肝切除的围手术期临床结局,还能预测其对支付方和医疗机构的财务影响。

研究设计与样本

  • 回顾性队列研究,纳入124例接受机器人肝切除的患者,应用Tampa机器人难度评分分为4组:组1(1-8分,n=16)、组2(9-24分,n=86)、组3(25-32分,n=17)、组4(33-49分,n=5)。
  • 采用单因素方差分析比较各组间财务指标,数据以中位数(均值±标准差)表示,统计显著性设定为p≤0.05。

主要发现

  • 随着难度评分增加,总住院费用显著增加(p<0.001)。
  • 可变成本显著增加(p<0.001)。
  • 固定直接成本显著增加(p<0.001),固定间接成本显著增加(p=0.017)。
  • 医院报销未随手术复杂度线性增加,导致最复杂病例(组4)对医疗机构产生不成比例的财务负担。

临床怎么用

  • 可用于机器人肝切除的术前手术规划,辅助预测技术挑战和财务影响。
  • 有助于资源分配和财务风险评估,尤其关注高难度病例的报销不足问题。

局限性

  • 研究为单中心回顾性内部验证,样本量有限,需外部验证以确认其在其他医疗环境和经济结构中的有效性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The robotic approach in hepatectomy is becoming increasingly prevalent, necessitating a dedicated difficulty scoring system tailored for robotic operations. The Tampa Robotic Difficulty Score serves this purpose by offering a novel robotic-specific scoring system designed to enhance preoperative surgical planning and predict potential technical challenges in robotic hepatectomies. Following its conceptualization, we sought to internally validate the Tampa Difficulty Score by correlating it with financial variables based on our recent cohort of patients, extending the score's applicability beyond clinical outcomes alone to encompass economic or financial factors. METHODS: We retrospectively applied the Tampa Difficulty Score to our latest cohort of 124 patients who underwent robotic hepatectomy. Patients were stratified into four technical difficulty levels: Group 1 (1-8, n = 16), Group 2 (9-24, n = 86), Group 3 (25-32, n = 17), and Group 4 (33-49, n = 5). We then examined the association between the groups and various financial metrics, including total hospital charges, variable costs, fixed costs, and hospital reimbursements. A one-way ANOVA was utilized for comparisons among the groups. Data are presented as median (mean ± standard deviation). Statistical significance was accepted at p ≤ 0.05. RESULTS: Analysis revealed a significant association between the Tampa Difficulty Score and financial metrics. With an increase in difficulty score, there was a significant increase in total hospital charges (p < 0.001), variable costs (p < 0.001), and fixed direct (p < 0.001) and indirect costs (p = 0.017). In contrast, hospital reimbursements did not linearly increase with the procedural complexity, leading to a non-proportionate financial burden on healthcare facilities, specifically seen in the most complex cases (Group 4). CONCLUSIONS: The Tampa Difficulty Score has demonstrated its utility not only in predicting perioperative clinical outcomes in patients undergoing robotic hepatectomy but also in projecting the financial impacts of robotic hepatectomy to payors and providing institution. This dual predictive capacity is valuable in preoperative surgical planning, resource allocation, and financial risk assessment. External validation of the Tampa Difficulty Score is an important next step to confirm its effectiveness in other healthcare settings and economic structures.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Pattilachan TM, Christodoulou M, Ross SB, et al. Internal validation of the Tampa Robotic Difficulty Scoring System: real-time assessment of the novel robotic scoring system in predicting financial costs of hepatectomy. Surg Endosc. 2026. PMID: 41545571. doi:10.1007/s00464-025-12543-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。